Competitive
Curiosity
Strategic
Sampling
ADA - Hygiene Schools
Call Continuum
DSO
100

What is the primary goal of Competitive Curiosity? 

What is staying curious and asking better questions rather than becoming an expert on every product?

100

What is the overall goal of the strategic sample workshop?

What is making strategic decisions that prioritize the greatest opportunity for business growth using limited resources?

100

What is the primary objective of Advil Dual Action education in academic settings?


What is building future dental professional recommenders of Advil Dual Action through pain management education while keeping oral care as the primary focus?

100

What makes a continued movement along the call continuum seem too hard or difficult?

A large ask too soon.

100

A national DSO contract is already in place, but the product isn't stocked, the hygienist is unfamiliar with it, and the office manager is overwhelmed. Your first priority is to create local adoption rather than assuming the contract will do the work.

What is engaging the Office Manager, RDH, and DDS to build local pull-through?

200

When an HCP mentions an unfamiliar product, what should you do first?

What is ask open-ended, curiosity-based questions to understand their rationale?

200

According to the workshop, samples should align with what three things?

What are the conversation, the relationship, and the commitment?

200

How much of an academic selling effort should Advil Dual Action represent?

What is no more than approximately 5% of the academic selling effort?

200

How do we continue to grow our brand recommendations?

Incremental shifts in recommendations

200

An independent office in your territory has just joined Smiles Dental, adding seven locations today and five more planned by year-end. Before expanding utilization, you should develop this.


What is a strategic DSO account plan with stakeholder mapping, information gathering, and a timeline?

300

Name two things you should try to uncover during a Competitive Curiosity conversation.

What are patient needs, compliance/adherence barriers, HCP decision-making, expected outcomes, or why they prefer the product?

300

True or False: Success is measured by leaving every office with the same number of samples.

What is False?
Explanation: The goal is to strategically invest resources—not distribute samples equally.

300

Why should representatives avoid leaving medication sample dispensers in hygiene schools?

What is because hygiene schools do not dispense medication, so sample dispensers should not be left for clinic use?

300

What is learned by TBM, what is asked of HCP, what is agreed follow up and what is entered every day?

Best practice call note entries.

300

While working your territory, you identify a new mid-level DSO opportunity. According to the DSO briefing, this team member should be contacted because they own these accounts.

Who is the National Account Manager (NAM)?

400

According to the workshop, what is the "rabbit hole" reps should avoid?

What is getting into detailed product specifics instead of asking general discovery questions and letting the HCP teach?

400

When managing a shared account, what is one key strategy discussed in the workshop?

What is collaborating with the TBM/ISR to avoid over- or under-sampling and ensure the HCO is supported appropriately?

400

If faculty members don't request deeper pain management education, what is the recommended educational approach in hygiene schools?

What is using the All Brands message as the standard educational approach?

400

 Why are quality call notes/pre call planning critical?

To Identify growth opportunities these 2 steps are critical.

400

A DSO has signed a national agreement, but offices still aren't consistently using your product. The best long-term strategy is to combine local stakeholder engagement with these activities to improve adoption across the organization.

What is national pull-through through in-services, promotional programs, coupon scans, and coordinated implementation?

500

After identifying patient needs or compliance barriers, what is the next step in the conversation?

What is confidently connecting the conversation back to Haleon's value, solutions, or an appropriate next step?

500

Complete the workshop's key takeaway: "The goal is not to give more samples—it's to give the ______ resources, to the ______ accounts, at the ______ time, for the ______ reason."

What are the right resources, the right accounts, the right time, and the right reason?

500

Name one statistic or guideline that supports educating future dental professionals about Advil Dual Action.

What is any one of the following?

  • Dentists drive 12% of recommendations for oral analgesics.
  • Dental pain impacts over 40% of adults annually.
  • The 2024 ADA guidelines recommend non-opioid analgesics as first-line therapy for dental pain.
  • Advil Dual Action is featured as a recommended OTC NSAID in the ADA guidelines.
500

What are 2 of the 5 Commitments to elevate our impact in offices?

Acknowledge first, then ask for a realistic step and scale the ask to the call continuum.

500

You inherit a territory where a DSO has a national agreement, inconsistent office access, multiple new hygienists, and varying levels of product adoption. Success will require combining everything learned in this module.

What is partnering with the NAM, engaging local stakeholders, creating a strategic implementation plan, and driving consistent pull-through at the office level?